Health
ESMO experts: Do not discontinue or delay cancer treatment impacting on overall survival. – Brinkwire
An ESMO interdisciplinary expert consensus paper on how to manage cancer patients during the COVID-19 pandemic has been published today in Annals of Oncology, encouraging medical oncologists worldwide not to discontinue or delay any type of anti-cancer treatment that may potentially impact on overall survival. The experts also urge to stop labelling all cancer patients as vulnerable to coronavirus infection since this may lead to inappropriate care and potential negative outcomes.
Coronavirus d…
-
General11 hours agoTributes flow after Australian Paralympic bronze medallist Nicholas Hum dies aged 32
-
Noosa News15 hours agoThree taken to hospital, crime scene declared after unit fire in Spring Hill
-
General20 hours agoAussies skipping dental, medical care to afford rent
-
Business19 hours agoWhat a rising Aussie dollar means for your ASX shares